$3.25
-0.25-7.14%
가까이에: Aug 24, 5:00 PM EST
$3.26
0.010.31%
시간외: 7:57 PM EST
Benzinga
Benzinga
Benzinga
화요일, 8월 25
Recursion Pharmaceuticals Inc
RXRXNASDAQ
Recursion Pharmaceuticals Earnings & Forecasts
Recursion Pharmaceuticals (RXRX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Recursion Pharmaceuticals Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.24 | $-0.27 | $-0.30 | $-0.38 |
| Actual | $-0.25 | $-0.22 | $-0.21 | $-0.36 |
| Surprise | -4.17% | +18.5% | +30.0% | +5.26% |
| Revenue | ||||
| Estimate | $12.9M | $15.9M | $24.9M | $18.6M |
| Actual | $7.7M | $6.5M | $35.5M | $5.2M |
| Surprise | -40.7% | -59.2% | +42.5% | -72.2% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.23 | $-0.22 | $-0.23 | $-0.24 |
| Revenue | ||||
| Consensus | $13.1M | $16.7M | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved